SCHEMBL29669239

SCHEMBL29669239

Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cccc(CNC(N)=O)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4384630 1.00 MAPK14 (1.00) MAPK14
SCHEMBL31079989 0.92 MAPK14 (0.86) MAPK14
SCHEMBL4387354 0.92 MAPK14 (0.86) MAPK14
SCHEMBL5862135 0.92 MAPK14 (1.00) MAPK14
SCHEMBL31079631 0.92 MAPK14 (1.00) MAPK14
SCHEMBL4379183 0.92 MAPK14 (0.84) MAPK14
Hydrochloric Acid SCHEMBL4377979 0.91 MAPK14 (0.98) MAPK14
SCHEMBL4385422 0.91 MAPK14 (0.83) MAPK14
SCHEMBL31139615 0.91 MAPK14 (1.00) MAPK14
SCHEMBL29593562 0.91 MAPK14 (0.83) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114732910-B P38 kinase inhibitors reduce DUX4 and downstream gene expression and treat FSHD 弗尔康医疗公司 2024-08-23 CN disclosed
CN-114748622-A P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD 弗尔康医疗公司 2022-07-15 CN disclosed
CN-114732910-A P38 kinase inhibitor reduces DUX4 and downstream gene expression for treatment of FSHD 弗尔康医疗公司 2022-07-12 CN disclosed